GPR55 (Serbo-Croatian Wikipedia)

Analysis of information sources in references of the Wikipedia article "GPR55" in Serbo-Croatian language version.

refsWebsite

Global rank Serbo-Croatian rank

13nih.gov

4^th place

3^rd place

12doi.org

2^nd place

5archive.org

6^th place

5^th place

archive.org (Global: 6^th place; Serbo-Croatian: 5^th place)

Brown AJ. (2007). „Novel cannabinoid receptors.”. Br J Pharmacol. 152 (5): 567–575. DOI:10.1038/sj.bjp.0707481. PMC 2190013. PMID 17906678.
Sawzdargo M, Nguyen T, Lee DK, Lynch KR, Cheng R, Heng HH, George SR, O'Dowd BF (1999). „Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain”. Brain Res. Mol. Brain Res. 64 (2): 193–8. DOI:10.1016/S0169-328X(98)00277-0. PMID 9931487.
Johns DG, Behm DJ, Walker DJ, Ao Z, Shapland EM, Daniels DA, Riddick M, Dowell S, Staton PC, Green P, Shabon U, Bao W, Aiyar N, Yue TL, Brown AJ, Morrison AD, Douglas SA (2007). „The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects”. Br. J. Pharmacol. 152 (5): 825–31. DOI:10.1038/sj.bjp.0707419. PMC 2190033. PMID 17704827.
Ryberg E, Larsson N, Sjögren S, Hjorth S, Hermansson NO, Leonova J, Elebring T, Nilsson K, Drmota T, Greasley PJ (2007). „The orphan receptor GPR55 is a novel cannabinoid receptor”. Br. J. Pharmacol. 152 (7): 1092–101. DOI:10.1038/sj.bjp.0707460. PMC 2095107. PMID 17876302.
Staton PC, Hatcher JP, Walker DJ, Morrison AD, Shapland EM, Hughes JP, Chong E, Mander PK, Green PJ, Billinton A, Fulleylove M, Lancaster HC, Smith JC, Bailey LT, Wise A, Brown AJ, Richardson JC, Chessell IP (September 2008). „The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain”. Pain 139 (1): 225–36. DOI:10.1016/j.pain.2008.04.006. PMID 18502582.

doi.org (Global: 2^nd place; Serbo-Croatian: 2^nd place)

dx.doi.org

Brown AJ. (2007). „Novel cannabinoid receptors.”. Br J Pharmacol. 152 (5): 567–575. DOI:10.1038/sj.bjp.0707481. PMC 2190013. PMID 17906678.
McHugh D, Hu SS, Rimmerman N, Juknat A, Vogil Z, Walker JM, Bradshaw HB (March 2010). „N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor”. BMC Neuroscience 11 (1): 44. DOI:10.1186/1471-2202-11-44. PMC 2865488. PMID 20346144.
Sawzdargo M, Nguyen T, Lee DK, Lynch KR, Cheng R, Heng HH, George SR, O'Dowd BF (1999). „Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain”. Brain Res. Mol. Brain Res. 64 (2): 193–8. DOI:10.1016/S0169-328X(98)00277-0. PMID 9931487.
Baker D, Pryce G, Davies WL, Hiley CR (2006). „In silico patent searching reveals a new cannabinoid receptor”. Trends Pharmacol. Sci. 27 (1): 1–4. DOI:10.1016/j.tips.2005.11.003. PMID 16318877.
Johns DG, Behm DJ, Walker DJ, Ao Z, Shapland EM, Daniels DA, Riddick M, Dowell S, Staton PC, Green P, Shabon U, Bao W, Aiyar N, Yue TL, Brown AJ, Morrison AD, Douglas SA (2007). „The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects”. Br. J. Pharmacol. 152 (5): 825–31. DOI:10.1038/sj.bjp.0707419. PMC 2190033. PMID 17704827.
Lauckner JE, Jensen JB, Chen HY, Lu HC, Hille B, Mackie K (2008). „GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current”. Proc. Natl. Acad. Sci. U.S.A. 105 (7): 2699–704. DOI:10.1073/pnas.0711278105. PMC 2268199. PMID 18263732.
Ryberg E, Larsson N, Sjögren S, Hjorth S, Hermansson NO, Leonova J, Elebring T, Nilsson K, Drmota T, Greasley PJ (2007). „The orphan receptor GPR55 is a novel cannabinoid receptor”. Br. J. Pharmacol. 152 (7): 1092–101. DOI:10.1038/sj.bjp.0707460. PMC 2095107. PMID 17876302.
Oka S, Nakajima K, Yamashita A, Kishimoto S, Sugiura T (November 2007). „Identification of GPR55 as a lysophosphatidylinositol receptor”. Biochemical and Biophysical Research Communications 362 (4): 928–34. DOI:10.1016/j.bbrc.2007.08.078. PMID 17765871.
Henstridge CM, Balenga NA, Ford LA, Ross RA, Waldhoer M, Irving AJ (January 2009). „The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation”. The FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology 23 (1): 183–93. DOI:10.1096/fj.08-108670. PMID 18757503.
Oka S, Toshida T, Maruyama K, Nakajima K, Yamashita A, Sugiura T (January 2009). „2-Arachidonoyl-sn-glycero-3-phosphoinositol: a possible natural ligand for GPR55”. Journal of Biochemistry 145 (1): 13–20. DOI:10.1093/jb/mvn136. PMID 18845565.
Staton PC, Hatcher JP, Walker DJ, Morrison AD, Shapland EM, Hughes JP, Chong E, Mander PK, Green PJ, Billinton A, Fulleylove M, Lancaster HC, Smith JC, Bailey LT, Wise A, Brown AJ, Richardson JC, Chessell IP (September 2008). „The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain”. Pain 139 (1): 225–36. DOI:10.1016/j.pain.2008.04.006. PMID 18502582.
Kress M, Kuner R (March 2009). „Mode of action of cannabinoids on nociceptive nerve endings”. Experimental Brain Research. Experimentelle Hirnforschung. Experimentation Cerebrale 196 (1): 79–88. DOI:10.1007/s00221-009-1762-0. PMID 19306092.

nih.gov (Global: 4^th place; Serbo-Croatian: 3^rd place)

ncbi.nlm.nih.gov

„Entrez Gene: GPR55 G protein-coupled receptor 55”.
Brown AJ. (2007). „Novel cannabinoid receptors.”. Br J Pharmacol. 152 (5): 567–575. DOI:10.1038/sj.bjp.0707481. PMC 2190013. PMID 17906678.
McHugh D, Hu SS, Rimmerman N, Juknat A, Vogil Z, Walker JM, Bradshaw HB (March 2010). „N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor”. BMC Neuroscience 11 (1): 44. DOI:10.1186/1471-2202-11-44. PMC 2865488. PMID 20346144.
Sawzdargo M, Nguyen T, Lee DK, Lynch KR, Cheng R, Heng HH, George SR, O'Dowd BF (1999). „Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain”. Brain Res. Mol. Brain Res. 64 (2): 193–8. DOI:10.1016/S0169-328X(98)00277-0. PMID 9931487.
Baker D, Pryce G, Davies WL, Hiley CR (2006). „In silico patent searching reveals a new cannabinoid receptor”. Trends Pharmacol. Sci. 27 (1): 1–4. DOI:10.1016/j.tips.2005.11.003. PMID 16318877.
Johns DG, Behm DJ, Walker DJ, Ao Z, Shapland EM, Daniels DA, Riddick M, Dowell S, Staton PC, Green P, Shabon U, Bao W, Aiyar N, Yue TL, Brown AJ, Morrison AD, Douglas SA (2007). „The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects”. Br. J. Pharmacol. 152 (5): 825–31. DOI:10.1038/sj.bjp.0707419. PMC 2190033. PMID 17704827.
Lauckner JE, Jensen JB, Chen HY, Lu HC, Hille B, Mackie K (2008). „GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current”. Proc. Natl. Acad. Sci. U.S.A. 105 (7): 2699–704. DOI:10.1073/pnas.0711278105. PMC 2268199. PMID 18263732.
Ryberg E, Larsson N, Sjögren S, Hjorth S, Hermansson NO, Leonova J, Elebring T, Nilsson K, Drmota T, Greasley PJ (2007). „The orphan receptor GPR55 is a novel cannabinoid receptor”. Br. J. Pharmacol. 152 (7): 1092–101. DOI:10.1038/sj.bjp.0707460. PMC 2095107. PMID 17876302.
Oka S, Nakajima K, Yamashita A, Kishimoto S, Sugiura T (November 2007). „Identification of GPR55 as a lysophosphatidylinositol receptor”. Biochemical and Biophysical Research Communications 362 (4): 928–34. DOI:10.1016/j.bbrc.2007.08.078. PMID 17765871.
Henstridge CM, Balenga NA, Ford LA, Ross RA, Waldhoer M, Irving AJ (January 2009). „The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation”. The FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology 23 (1): 183–93. DOI:10.1096/fj.08-108670. PMID 18757503.
Oka S, Toshida T, Maruyama K, Nakajima K, Yamashita A, Sugiura T (January 2009). „2-Arachidonoyl-sn-glycero-3-phosphoinositol: a possible natural ligand for GPR55”. Journal of Biochemistry 145 (1): 13–20. DOI:10.1093/jb/mvn136. PMID 18845565.
Staton PC, Hatcher JP, Walker DJ, Morrison AD, Shapland EM, Hughes JP, Chong E, Mander PK, Green PJ, Billinton A, Fulleylove M, Lancaster HC, Smith JC, Bailey LT, Wise A, Brown AJ, Richardson JC, Chessell IP (September 2008). „The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain”. Pain 139 (1): 225–36. DOI:10.1016/j.pain.2008.04.006. PMID 18502582.
Kress M, Kuner R (March 2009). „Mode of action of cannabinoids on nociceptive nerve endings”. Experimental Brain Research. Experimentelle Hirnforschung. Experimentation Cerebrale 196 (1): 79–88. DOI:10.1007/s00221-009-1762-0. PMID 19306092.

GPR55 (Serbo-Croatian Wikipedia)

archive.org (Global: 6th place; Serbo-Croatian: 5th place)

doi.org (Global: 2nd place; Serbo-Croatian: 2nd place)

dx.doi.org

nih.gov (Global: 4th place; Serbo-Croatian: 3rd place)

ncbi.nlm.nih.gov

archive.org (Global: 6^th place; Serbo-Croatian: 5^th place)

doi.org (Global: 2^nd place; Serbo-Croatian: 2^nd place)

nih.gov (Global: 4^th place; Serbo-Croatian: 3^rd place)